Human umbilical cord tissue-derived mesenchymal stromal cells as adjuvant therapy for myocardial infarction: a review of current evidence focusing on pre-clinical large animal models and early human trials.

Cytotherapy
Luís RaposoAdelino Leite-Moreira

Abstract

Although biologically appealing, the concept of tissue regeneration underlying first- and second-generation cell therapies has failed to translate into consistent results in clinical trials. Several types of cells from different origins have been tested in pre-clinical models and in patients with acute myocardial infarction (AMI). Mesenchymal stromal cells (MSCs) have gained attention because of their potential for immune modulation and ability to promote endogenous tissue repair, mainly through their secretome. MSCs can be easily obtained from several human tissues, the umbilical cord being the most abundant source, and further expanded in culture, making them attractive as an allogeneic "of-the-shelf" cell product, suitable for the AMI setting. The available evidence concerning umbilical cord-derived MSCs in AMI is reviewed, focusing on large animal pre-clinical studies and early human trials. Molecular and cellular mechanisms as well as current limitations and possible translational solutions are also discussed.

References

Apr 5, 2001·Nature·D OrlicP Anversa
Dec 8, 2004·Stem Cells·Hwai-Shi WangChin-Chang Chen
Apr 23, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Katarina Le Blanc, Olle Ringdén
Sep 23, 2006·The New England Journal of Medicine·Volker SchächingerUNKNOWN REPAIR-AMI Investigators
Aug 25, 2007·Journal of Molecular and Cellular Cardiology·Kaomei Guan, Gerd Hasenfuss
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Feb 22, 2008·Nature·Vincent F M Segers, Richard T Lee
May 15, 2010·Journal of the American College of Cardiology·Ana ArmiñánPilar Sepúlveda
Jun 19, 2010·Journal of Cardiovascular Translational Research·Husnain Kh Haider, Muhammad Ashraf
Nov 26, 2010·Stem Cell Research & Therapy·Bruce A BunnellDeborah E Sullivan
Dec 15, 2010·Journal of Cellular and Molecular Medicine·Hongwei ShaoHong Yu
Mar 26, 2011·Stem Cells International·Martin H Maurer
Aug 26, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Marilena LupuJürgen Hescheler
Jul 14, 2012·Nature Protocols·Frederic C McCallJoshua M Hare
Sep 25, 2012·Journal of the American College of Cardiology·Eduardo MarbánEugenio Cingolani
Oct 19, 2013·Physiological Reviews·Jean-Sébastien SilvestreBernard I Lévy
Mar 29, 2014·Circulation. Cardiovascular Interventions·Renate de JongHenricus J Duckers
May 31, 2015·Heart Failure Reviews·Jianqin Ye, Yerem Yeghiazarians
Jan 1, 2013·Journal of Clinical Medicine·Sveva BolliniRanieri Cancedda
Nov 4, 2015·International Journal of Cardiology·Yuli HuangWeiyi Mai
Jun 9, 2016·Tissue Engineering. Part B, Reviews·Maribella DomenechDonald O Freytes
Jul 21, 2016·Circulation Research·Ibhar Al MheidArshed A Quyyumi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.